Table 4.
Gene | Cases < 60 at diagnosis (n = 4132) | Cases ≥ 60 at diagnosis (n = 3564) | |||||||
---|---|---|---|---|---|---|---|---|---|
|
|
|
|||||||
OC cases tested | Cases with P/LP | % positive | OC cases tested | Cases with P/LP | % positive | OR | 95% CI | p-Value | |
ATM | 3341 | 34 | 1.0 | 2916 | 19 | 0.65 | 1.57 | 0.87–2.92 | 0.11 |
BRCA1 | 3975 | 226 | 5.7 | 3451 | 70 | 2.0 | 2.91 | 2.21–3.88 | 8.90 × 10−16 |
BRCA2 | 3975 | 121 | 3.0 | 3451 | 129 | 3.7 | 0.81 | 0.62–1.05 | 0.10 |
BRIP1 | 3330 | 19 | 0.57 | 2906 | 42 | 1.4 | 0.39 | 0.21–0.69 | 0.0005 |
MSH2 | 3928 | 25 | 0.64 | 3421 | 3 | 0.09 | 7.3 | 2.22–37.8 | 0.0001 |
MSH6 | 3928 | 43 | 1.1 | 3421 | 5 | 0.15 | 7.56 | 3.00–24.5 | 4.80 × 10−7 |
NBN | 3330 | 13 | 0.39 | 2906 | 11 | 0.38 | 1.05 | 0.41–2.71 | 0.91 |
PALB2 | 3350 | 10 | 0.3 | 2929 | 13 | 0.44 | 0.67 | 0.26–1.66 | 0.34 |
RAD51C | 3330 | 29 | 0.87 | 2906 | 21 | 0.72 | 1.21 | 0.66–2.23 | 0.51 |
RAD51D | 3020 | 5 | 0.17 | 2675 | 13 | 0.49 | 0.34 | 0.09–1.02 | 0.03 |